FDA clears Vasomedical's Holter monitors

Brian Dunham | | Health Imaging | Screening
Vasomedical has received FDA market clearance for two new monitors: the Biox Model 1303 3-channel ECG Holter Monitor and Model 1304 12-channel ECG Holter Monitor.

The approval of the two new monitors completes a line of ambulatory monitoring products for long-term recording and analysis of ECG and blood pressure data, according to the company. Vasomedical added that its Biox monitors work with CB Series Analysis Software.

Vasomedical will showcase its Biox products at the upcoming Florida International Medical Expo in Miami Beach, Fla., from Aug. 11-12 and the European Society of Cardiology Congress in Paris, Aug. 27-30.

Brian Dunham

Related Content

Routine abdominal CTs offer insight into cardiovascular risk
Screening efforts have helped avert millions of cancer-related deaths in recent decades
What breast density status can tell us about cardiovascular risk
FDA clears AI tool that flags signs of heart disease in chest CT scans
Patients without PCPs struggle to access lung cancer screening, despite eligibility
Breast cancer rates among women in their 30s are on the rise

Around the web

Radiology Business
Key Medicare reimbursement and No Surprises Act updates from RSNA 2024

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

Cardiovascular Business
Philips, Mayo Clinic using AI to improve cardiac MRI technology

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.

Cardiovascular Business
Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services.